NYSE:PRGO - Perrigo Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $47.33
Forecasted Upside: 9.19 %
Number of Analysts: 3
Breakdown:
0 Sell Ratings
3 Hold Ratings
0 Buy Ratings
0 Strong Buy Ratings

^$43.35 As of 09/27/2021 01:00 AM ET

▲ +0.35 (0.81%)

1 month | 3 months | 12 months

Get New Perrigo Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for PRGO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PRGO

^$47.33

▲ +9.19% Upside Potential

This price target is based on 3 analysts offering 12 month price targets for Perrigo in the last 3 months. The average price target is $47.33, with a high forecast of $49.00 and a low forecast of $45.00. The average price target represents a 9.19% upside from the last price of $43.35.

Current Consensus is Hold

The current consensus among 3 polled investment analysts is to hold stock in Perrigo. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
3 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

4/5/2020

0 strong buy ratings
3 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

7/4/2020

0 strong buy ratings
3 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

10/2/2020

0 strong buy ratings
3 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

12/31/2020

0 strong buy ratings
1 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

3/31/2021

0 strong buy ratings
1 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

6/29/2021

0 strong buy ratings
1 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

8/28/2021

0 strong buy ratings
0 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

9/27/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
8/12/2021	Royal Bank of Canada	Lower Price Target	Sector Perform	$51.00 ➝ $48.00	High
4/7/2021	Royal Bank of Canada	Initiated Coverage	Sector Perform	$51.00	Medium
3/5/2021	Morgan Stanley	Lower Price Target	Equal Weight	$53.00 ➝ $45.00	Low
1/6/2021	Royal Bank of Canada	Downgrade	Outperform ➝ Sector Perform	$59.00 ➝ $49.00	N/A
10/28/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$55.00 ➝ $49.00	Low
9/17/2020	SVB Leerink	Lower Price Target	Outperform	$64.00 ➝ $63.00	High
6/8/2020	SVB Leerink	Boost Price Target	Outperform	$55.00 ➝ $63.00	High
6/7/2020	Royal Bank of Canada	Reiterated Rating	Buy		High
4/17/2020	Argus	Downgrade	Buy ➝ Hold		High
4/2/2020	Morgan Stanley	Lower Price Target	Equal Weight	$54.00 ➝ $53.00	High
4/1/2020	Royal Bank of Canada	Reiterated Rating	Buy	$58.00	High
3/24/2020	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$57.00	Medium
3/20/2020	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$54.00 ➝ $52.00	High
3/18/2020	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$58.00	High
3/11/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$63.00 ➝ $53.00	High
2/28/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$64.00 ➝ $58.00	High
1/21/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$60.00 ➝ $70.00	Medium
10/11/2019	Argus	Upgrade	Hold ➝ Buy		Low
9/30/2019	Wells Fargo & Company	Boost Price Target	Market Perform	$45.00 ➝ $52.00	Medium
9/25/2019	SunTrust Banks	Boost Price Target	Hold	$51.00 ➝ $55.00	Medium
7/2/2019	Wells Fargo & Company	Reiterated Rating	Hold		Low
6/19/2019	Wells Fargo & Company	Set Price Target	Hold	$45.00	High
6/12/2019	Cantor Fitzgerald	Lower Price Target	Overweight	$107.00 ➝ $60.00	Low
5/20/2019	SunTrust Banks	Boost Price Target	Hold	$51.00	Medium
5/8/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$107.00	High
4/4/2019	SunTrust Banks	Lower Price Target	Hold	$46.00	High
3/26/2019	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$67.00 ➝ $54.00	High
3/19/2019	SunTrust Banks	Initiated Coverage	Hold ➝ Hold	$51.00	Medium
2/28/2019	Royal Bank of Canada	Set Price Target	Hold	$48.00	Medium
2/28/2019	Wells Fargo & Company	Set Price Target	Hold	$47.00	Medium
1/4/2019	Royal Bank of Canada	Set Price Target	Hold	$50.00	High
12/30/2018	Wells Fargo & Company	Set Price Target	Hold	$46.00	Low
12/30/2018	Morgan Stanley	Set Price Target	Hold	$67.00	Low
12/24/2018	SVB Leerink	Lower Price Target		$70.00 ➝ $56.00	Medium
12/23/2018	Morgan Stanley	Set Price Target	Hold	$67.00	Medium
12/21/2018	Wells Fargo & Company	Lower Price Target	Market Perform ➝ Market Perform	$64.00 ➝ $46.00	High
12/20/2018	Cantor Fitzgerald	Set Price Target	Buy PRGO	$107.00	High
11/14/2018	Wells Fargo & Company	Lower Price Target	Market Perform	$77.00 ➝ $64.00	Low
11/13/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Hold	$77.00 ➝ $67.00	Low
11/13/2018	Berenberg Bank	Downgrade	Buy ➝ Hold	$100.00 ➝ $72.00	Low
11/9/2018	Royal Bank of Canada	Set Price Target	Hold	$63.00	Medium
10/8/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$107.00	High
8/21/2018	Wells Fargo & Company	Lower Price Target	Market Perform ➝ Market Perform	$84.00 ➝ $77.00	Low
8/17/2018	Canaccord Genuity	Set Price Target	Buy	$90.00	Low
8/10/2018	Jefferies Financial Group	Reiterated Rating	Hold	$73.00	Low
8/10/2018	JPMorgan Chase & Co.	Lower Price Target	Neutral ➝ Neutral	$83.00 ➝ $75.00	N/A
8/10/2018	Royal Bank of Canada	Lower Price Target	Sector Perform ➝ Hold	$89.00 ➝ $67.00	N/A
8/10/2018	Stifel Nicolaus	Lower Price Target	Hold	$92.00 ➝ $87.00	Low
8/10/2018	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$93.00 ➝ $78.00	Low
8/9/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	High
7/30/2018	Argus	Downgrade	Buy ➝ Hold		Medium
7/18/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$107.00	Medium
7/12/2018	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell	$78.00 ➝ $74.00	Low
6/22/2018	Cantor Fitzgerald	Reiterated Rating	Overweight		Low
6/18/2018	Morgan Stanley	Reiterated Rating	Equal Weight	$85.00	Low
6/6/2018	Barclays	Downgrade	Overweight ➝ Equal Weight	$110.00	Low
5/23/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
5/14/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
5/14/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
5/14/2018	Wells Fargo & Company	Lower Price Target	Market Perform ➝ Market Perform	$90.00 ➝ $84.00	High
5/11/2018	Oppenheimer	Set Price Target	Buy	$98.00	Low
5/8/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
4/23/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
4/16/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
4/9/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
3/26/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
3/12/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
3/5/2018	Oppenheimer	Set Price Target	Buy	$98.00	Low
3/5/2018	JPMorgan Chase & Co.	Reiterated Rating	Neutral ➝ Neutral	$82.00 ➝ $83.00	Low
3/5/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
3/1/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	High
2/27/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Medium
2/27/2018	Oppenheimer	Reiterated Rating	Buy	$98.00	High
2/23/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
2/16/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
2/9/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
2/1/2018	Berenberg Bank	Initiated Coverage	Buy	$117.00	Low
1/19/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
1/17/2018	Canaccord Genuity	Reiterated Rating	Buy	$100.00	Low
1/12/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
1/5/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
1/2/2018	SVB Leerink	Initiated Coverage	Mkt Perform ➝ Market Perform	$90.00	Low
1/1/2018	Canaccord Genuity	Set Price Target	Buy	$100.00	High
12/28/2017	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
12/26/2017	Canaccord Genuity	Set Price Target	Buy	$100.00	Low
12/22/2017	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
12/16/2017	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
12/10/2017	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
12/8/2017	Argus	Upgrade	Hold ➝ Buy	$93.00	Medium
12/4/2017	Cantor Fitzgerald	Set Price Target	Buy	$107.00	High
12/4/2017	Barclays	Boost Price Target	Overweight	$93.00	Medium
11/28/2017	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
11/15/2017	Cantor Fitzgerald	Set Price Target	Buy	$107.00	N/A
11/10/2017	Jefferies Financial Group	Reiterated Rating	Hold	$81.00	N/A
11/10/2017	Wells Fargo & Company	Boost Price Target	Market Perform	$90.00	N/A
11/10/2017	Morgan Stanley	Boost Price Target	Equal Weight	$79.00 ➝ $92.00	N/A
11/10/2017	Royal Bank of Canada	Upgrade	Underperform ➝ Sector Perform	$64.00 ➝ $86.00	N/A
11/9/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$107.00	N/A
10/29/2017	Jefferies Financial Group	Set Price Target	Hold	$71.00	N/A
10/20/2017	Cantor Fitzgerald	Set Price Target	Buy	$107.00	N/A
10/5/2017	UBS Group	Reiterated Rating	Buy ➝ Buy	$84.00 ➝ $98.00	N/A
10/2/2017	Oppenheimer	Initiated Coverage	Buy	$88.00	Low
9/14/2017	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$88.00 ➝ $95.00	Low
9/13/2017	Royal Bank of Canada	Reiterated Rating	Sell	$64.00	Low
9/13/2017	Canaccord Genuity	Reiterated Rating	Buy	$88.00 ➝ $100.00	Low
9/12/2017	Cantor Fitzgerald	Boost Price Target	Overweight	$93.00 ➝ $107.00	Low
9/7/2017	CIBC	Initiated Coverage	Outperform ➝ Outperform	$88.00	Low
9/7/2017	Oppenheimer	Initiated Coverage	Outperform	$88.00	High
8/21/2017	Cantor Fitzgerald	Reiterated Rating	Buy		Low
8/15/2017	Wells Fargo & Company	Reiterated Rating	Market Perform	$77.00	Low
8/11/2017	Stifel Nicolaus	Reiterated Rating	Hold		Low
8/11/2017	Jefferies Financial Group	Reiterated Rating	Hold	$69.00 ➝ $71.00	Low
8/11/2017	Royal Bank of Canada	Boost Price Target	Underperform	$60.00 ➝ $64.00	Medium
8/11/2017	The Goldman Sachs Group	Upgrade	Sell ➝ Neutral	$66.00 ➝ $79.00	Medium
8/10/2017	Cantor Fitzgerald	Set Price Target	Buy	$85.00 ➝ $93.00	Low
8/10/2017	Canaccord Genuity	Reiterated Rating	Buy	$80.00 ➝ $88.00	High
7/24/2017	Cantor Fitzgerald	Set Price Target	Buy	$85.00	Low
7/17/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$86.00 ➝ $88.00	High
7/16/2017	Royal Bank of Canada	Set Price Target	Sell	$60.00	High
6/16/2017	Cantor Fitzgerald	Initiated Coverage	Overweight ➝ Overweight	$85.00	Low
6/5/2017	Royal Bank of Canada	Downgrade	Sector Perform ➝ Underperform	$66.00 ➝ $60.00	Low
6/1/2017	Barclays	Reiterated Rating	Overweight	$100.00 ➝ $85.00	Low
5/31/2017	Canaccord Genuity	Set Price Target	Buy	$80.00	Low
5/31/2017	The Goldman Sachs Group	Reiterated Rating	Sell	$68.00	High
5/24/2017	Royal Bank of Canada	Reiterated Rating	Hold	$66.00	Low
5/24/2017	Jefferies Financial Group	Reiterated Rating	Hold	$71.00	Medium
5/22/2017	Canaccord Genuity	Set Price Target	Buy	$86.00	Low
5/3/2017	Royal Bank of Canada	Reiterated Rating	Hold	$68.00	Low
4/22/2017	B. Riley	Reiterated Rating	Neutral	$67.00	Medium
4/19/2017	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$87.00 ➝ $86.00	Low
4/14/2017	Wells Fargo & Company	Reiterated Rating	Market Perform	$67.00	N/A
3/18/2017	Canaccord Genuity	Set Price Target	Buy	$86.00	Medium
3/14/2017	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$93.00 ➝ $87.00	Low
3/8/2017	B. Riley	Reiterated Rating	Neutral	$67.00	Low
3/3/2017	B. Riley	Reiterated Rating	Neutral ➝ Neutral	$83.00 ➝ $67.00	N/A
3/1/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$95.00 ➝ $93.00	N/A
2/28/2017	Jefferies Financial Group	Set Price Target	Hold	$70.00 ➝ $71.00	N/A
2/28/2017	Guggenheim	Reiterated Rating	Buy	$125.00	N/A
2/28/2017	Royal Bank of Canada	Lower Price Target		$68.00	N/A
2/28/2017	Canaccord Genuity	Boost Price Target	Buy	$97.00 ➝ $100.00	N/A
2/27/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform	$80.00	N/A
2/21/2017	Canaccord Genuity	Initiated Coverage	Buy ➝ Buy	$100.00	N/A
2/6/2017	Barclays	Lower Price Target	Overweight	$110.00 ➝ $100.00	N/A
2/6/2017	Guggenheim	Reiterated Rating	Buy	$125.00	N/A
1/30/2017	The Goldman Sachs Group	Reiterated Rating	Sell		N/A
1/29/2017	B. Riley	Reiterated Rating	Neutral	$83.00	N/A
1/24/2017	B. Riley	Reiterated Rating	Neutral	$83.00	N/A
1/24/2017	Guggenheim	Reiterated Rating	Buy	$125.00	N/A
1/23/2017	Jefferies Financial Group	Lower Price Target	Hold	$84.00 ➝ $70.00	N/A
1/17/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform	$92.00 ➝ $85.00	N/A
1/17/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$92.00 ➝ $85.00	N/A
12/23/2016	Guggenheim	Reiterated Rating	Buy	$125.00	N/A
11/16/2016	B. Riley	Reiterated Rating	Neutral	$97.00	N/A
11/11/2016	B. Riley	Reiterated Rating	Neutral	$87.00 ➝ $97.00	N/A
11/11/2016	Bank of America	Upgrade	Underperform ➝ Neutral		N/A
11/10/2016	JPMorgan Chase & Co.	Set Price Target	Hold	$95.00	N/A
11/10/2016	UBS Group	Set Price Target	Buy	$110.00	N/A
10/24/2016	Royal Bank of Canada	Set Price Target	Hold	$92.00	N/A
9/27/2016	Argus	Reiterated Rating	Hold		N/A

(Data available from 9/27/2016 forward)

News Sentiment Rating

0.30 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

0 very positive mentions
8 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/1/2021

0 very positive mentions
14 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/31/2021

0 very positive mentions
6 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

4/30/2021

0 very positive mentions
10 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

5/30/2021

0 very positive mentions
3 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

6/29/2021

1 very positive mentions
9 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

7/29/2021

0 very positive mentions
17 positive mentions
5 negative mentions
4 very negative mentions

Mentions as of

8/28/2021

5 very positive mentions
16 positive mentions
4 negative mentions
0 very negative mentions

Mentions as of

9/27/2021

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Perrigo Co. Plc provides self-care products and over-the-counter (OTC) health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Today's Range

Now: $43.35

$43.15

$43.89

50 Day Range

MA: $43.94

$39.75

$49.17

52 Week Range

Now: $43.35

$38.20

$49.91

Volume

886,742 shs

Average Volume

1,500,213 shs

Market Capitalization

$5.80 billion

P/E Ratio

N/A

Dividend Yield

2.23%

Beta

1.17

Frequently Asked Questions

What sell-side analysts currently cover shares of Perrigo?: The following Wall Street sell-side analysts have issued stock ratings on Perrigo in the last twelve months: Morgan Stanley, Royal Bank of Canada, and Wells Fargo & Company.
View the latest analyst ratings for PRGO.
What is the current price target for Perrigo?: 3 Wall Street analysts have set twelve-month price targets for Perrigo in the last year. Their average twelve-month price target is $47.33, suggesting a possible upside of 9.2%. Wells Fargo & Company has the highest price target set, predicting PRGO will reach $49.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $45.00 for Perrigo in the next year.
View the latest price targets for PRGO.
What is the current consensus analyst rating for Perrigo?: Perrigo currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PRGO, but not buy more shares or sell existing shares.
View the latest ratings for PRGO.
What other companies compete with Perrigo?: Other companies that are similar to Perrigo include Johnson & Johnson, Pfizer, Eli Lilly and, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb, Zoetis, Horizon Therapeutics Public, Royalty Pharma, Jazz Pharmaceuticals, Nektar Therapeutics, Pacira BioSciences, Corcept Therapeutics, Supernus Pharmaceuticals and Omeros.
How do I contact Perrigo's investor relations team?: Perrigo's physical mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company's listed phone number is (531) 709-4000 and its investor relations email address is [email protected] The official website for Perrigo is www.perrigo.com.

NYSE:PRGO - Perrigo Stock Price Target and Predictions

Analyst Price Target for PRGO

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.30 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Perrigo?

What is the current price target for Perrigo?

What is the current consensus analyst rating for Perrigo?

What other companies compete with Perrigo?

How do I contact Perrigo's investor relations team?